Mehrdad Zarghami: Evaluating aPL Prevalence and Recurrence Risk in Ischemic Stroke
Mehrdad Zarghami, Internal Medicine Resident at Jamaica Medical Center Hospital, Postdoctoral Researcher of Harvard Medical School, shared a post on LinkedIn about a recent article by Nathan W. Watson et al., published in Stroke, adding:
“Excited to share our newly published systematic review and meta-analysis in Stroke
‘Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke.’
In this analysis of 52 studies, we evaluated the prevalence of antiphospholipid antibodies (aPL) and their association with first and recurrent ischemic stroke.
Key findings included:
Nearly 1 in 5 patients with ischemic stroke were aPL-positive — pooled prevalence 19.1%.
aPL positivity was associated with almost 3-fold higher odds of first ischemic stroke (OR 2.93).
Lupus anticoagulant showed the strongest association, with OR 6.69.
Importantly, aPL positivity was not significantly associated with recurrent ischemic stroke in the available data (OR 1.20).
These findings highlight the potential importance of antiphospholipid antibodies in the evaluation and risk characterization of patients presenting with ischemic stroke, while also underscoring important questions regarding recurrence and long-term management.
Grateful to Nathan Watson, Syed Bukhari, Sina Rashedi, Behnood Bikdeli, and the entire multidisciplinary team for the opportunity to contribute to this collaborative work.”
Title: Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis
Authors: Nathan W. Watson, Syed Bukhari, Sina Rashedi, Mariana Pfeferman, Francisco Ujueta, Bassil Bacare, Brittany N. Weber, Mehrdad Zarghami, Yogendra Kanthi, Eric A. Secemsky, Jean M. Connors, Geoffrey D. Barnes, Sacha Uljon, Samuel Z. Goldhaber, Jeffrey I. Weitz, Karen H. Costenbader, Harlan M. Krumholz, Gregory Piazza, Mary Cushman, Christopher D. Anderson, Mitchell S. V. Elkind, Behnood Bikdeli
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 15, 2026, 07:39Sian James: Welsh Blood Service Research Showcases Innovation and International Collaboration in Transfusion Medicine
-
Oct 15, 2026, 07:16Ruhi Mehra: Advancing Modern Transfusion Medicine Through Collaboration and Continuing Medical Education
-
Oct 15, 2026, 07:08Muhammet Özbilen: Iron Deficiency Beyond Hemoglobin Exploring Mitochondrial and Metabolic Dysfunction
-
Oct 15, 2026, 06:44Ahlem Slama: World Thrombosis Day 2026 Lighting Up Heritage to Raise Awareness
-
Oct 15, 2026, 06:32Joshua Muia: World Thrombosis Day 2026 Highlights Research on Tissue Factor and Blood Coagulation
-
Oct 14, 2026, 20:36How Does Inflammation Reshape Red Blood Cell Production? – ASH
-
Oct 14, 2026, 20:30Marilena Vrana: Putting Faces to the Chain – Donors and Patients Connect in Milan for IPAW 2026
-
Oct 14, 2026, 20:25Asim Alam: Hillsborough County and Partners Demonstrate Drone-Based Emergency Blood Delivery
-
Oct 14, 2026, 20:19Zahid Khanzada: 3rd Position in the Hematology Quiz at PCUH